| Yahoo! Health - My Alerts - Edit Alert |
| Tuesday, Mar 12, 2013 04:11 PM EDT | |
| Mark March 26 as day to assess your diabetes risk in event at UAB Tue, 12 Mar, 2013 11:51 AM PDT Â BIRMINGHAM, Alabama -- Learn about your risks for diabetes on campus at UAB on March 26 in an event sponsored by the American Diabetes Association.It's called Alert Day and is billed as a one-day "wake-up call" to challenge... Encouraging Data Presented by Gilead - Analyst Blog Tue, 12 Mar, 2013 11:39 AM PDT Gilead Sciences, Inc. ( GILD ) recently presented encouraging data on its chronic angina drug Ranexa (ranolazine) from a phase IV study (TERISA: n=927). The TERISA (Type 2 Diabetes Investigating diabetes, obesity and high blood pressure fuseworks.co.nz Tue, 12 Mar, 2013 11:21 AM PDT The University of Canterbury (UC) is this year looking to investigate the risk factors of diabetes, obesity and high blood pressure to understand the relationship they have with the genesis of Alzheimerâs Disease. A UC bioengineering research team aims to provide a numerical model of the regulated blood supply with connected cells for the whole brain, which could model regulation of blood flow ... SBHSâ Ready2Move Club Receives Fund for Santa Barbaraâs Youth Making Change Grant for 2013 Week of Wellness, Brain ... Tue, 12 Mar, 2013 11:07 AM PDT High school health advocacy club provided by Sansum Diabetes Research Institute focuses on reducing obesity and preventing type 2 diabetes. Drug reduces chest pain in patients with diabetes Tue, 12 Mar, 2013 10:38 AM PDT A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to new research. BUSM study reveals therapeutic targets to alter inflammation, type 2 diabetes Tue, 12 Mar, 2013 10:07 AM PDT ( Boston University Medical Center ) New research from Boston University School of Medicine reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The study, published in the Proceedings of the National Academy of Sciences, indicates the importance of continuing to explore B cells as a therapeutic target to treat these diseases. Patents and Diagnostics Tue, 12 Mar, 2013 09:48 AM PDT Intellectual property claims may hinder using genomic tools for the betterment of public health, particularly for combating non-communicable diseases like type 2 diabetes, writes Anna George , an adjunct professor at Murdoch University in Australia and a Chatham House associate fellow, at the Guardian Professional . She estimates that about 20 percent of the human genome "is subject to patents ... Center for Diabetes Education offers March 18 program Tue, 12 Mar, 2013 09:42 AM PDT WARWICK â" The key to keeping blood glucose levels at your goal is to balance the food you eat with your physical activity and any pills or insulin you take. Cellnovo Selects Flextronics As Manufacturing And Design Partner Tue, 12 Mar, 2013 09:28 AM PDT SAN JOSE, Calif. and SWANSEA, Wales, March 12, 2013 /PRNewswire/ -- Cellnovo, developer of the first mobile diabetes management system, and Flextronics (NASDAQ: FLEX), today announced that the two companies have entered into an agreement whereby Flextronics will manufacture and provide... | |
|

No comments:
Post a Comment